Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and molecular and genetic alterations

Y Nakanuma, K Uesaka, Y Kakuda, T Sugino… - Journal of Clinical …, 2020 - mdpi.com
Intraductal papillary neoplasm of the bile duct (IPNB), a pre-invasive neoplasm of the bile
duct, is being established pathologically as a precursor lesion of invasive …

The repertoire of mutational signatures in human cancer

LB Alexandrov, J Kim, NJ Haradhvala, MN Huang… - Nature, 2020 - nature.com
Somatic mutations in cancer genomes are caused by multiple mutational processes, each of
which generates a characteristic mutational signature. Here, as part of the Pan-Cancer …

Genomic landscape of cancer in racially and ethnically diverse populations

CE Thomas, U Peters - Nature Reviews Genetics, 2024 - nature.com
Cancer incidence and mortality rates can vary widely among different racial and ethnic
groups, attributed to a complex interplay of genetic, environmental and social factors …

Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor

SMA Islam, M Díaz-Gay, Y Wu, M Barnes, R Vangara… - Cell genomics, 2022 - cell.com
Mutational signature analysis is commonly performed in cancer genomic studies. Here, we
present SigProfilerExtractor, an automated tool for de novo extraction of mutational …

The mutational signature profile of known and suspected human carcinogens in mice

L Riva, AR Pandiri, YR Li, A Droop, J Hewinson… - Nature …, 2020 - nature.com
Epidemiological studies have identified many environmental agents that appear to
significantly increase cancer risk in human populations. By analyzing tumor genomes from …

The repertoire of mutational signatures in human cancer

LB Alexandrov, J Kim, NJ Haradhvala, MN Huang… - BioRxiv, 2018 - biorxiv.org
Somatic mutations in cancer genomes are caused by multiple mutational processes each of
which generates a characteristic mutational signature. Using 84,729,690 somatic mutations …

Liver cancer study group of Japan clinical practice guidelines for intrahepatic cholangiocarcinoma

S Kubo, H Shinkawa, Y Asaoka, T Ioka, H Igaki, N Izumi… - Liver Cancer, 2022 - karger.com
This paper presents the first version of clinical practice guidelines for intrahepatic
cholangiocarcinoma (ICC) established by the Liver Cancer Study Group of Japan. These …

Mutational signatures are markers of drug sensitivity of cancer cells

J Levatić, M Salvadores, F Fuster-Tormo… - Nature …, 2022 - nature.com
Genomic analyses have revealed mutational footprints associated with DNA maintenance
gone awry, or with mutagen exposures. Because cancer therapeutics often target DNA …

[HTML][HTML] Hypermutation and microsatellite instability in gastrointestinal cancers

K Yuza, M Nagahashi, S Watanabe, K Takabe… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Recent progress in cancer genome analysis using next-generation sequencing has
revealed a high mutation burden in some tumors. The particularly high rate of somatic …

[HTML][HTML] Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair

DH Phillips - DNA repair, 2018 - Elsevier
Reporter gene assays, in which a single mutation from each experiment can contribute to
the assembly of a mutation spectrum for an agent, have provided the basis for …